Biocon to sell stake in biosimilar arm and Syngene: Sources
Biocon initiates talks for potential stake sale in biosimilar arm and Syngene, as per sources. What will the funds be utilised for? From the key factors to Biocon stake sale over the years, ET NOW's Srishti Sharma is here with all the details.
Other News Videos
'Tough times never last, tough nations do': Ambani seeks fresh RIL momentum after Rs 1.5 lakh cr...
$320 billion danger: Why 70 EM funds still remain underweight on India
RIL AGM 2026: Date, Time & 4 Big Things to Watch (Jio IPO, Retail, Energy)
SpaceX IPO LIVE | Elon Musk becomes world's first trillionaire as company makes historic debut
SEBI unveils Pilot DLT tokenisation project as risk evaluation process continues